Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ · Healthcare
Recursion Pharmaceuticals, Inc. Gross Profit 2019–2025
Recursion Pharmaceuticals, Inc. annual/quarterly gross profit history and growth rate from 2020 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Recursion Pharmaceuticals, Inc. gross profit for the quarter ending March 31, 2026 was -6.0 M, a 15.05% decrease year-over-year.
- Recursion Pharmaceuticals, Inc. gross profit for the twelve months ending March 31, 2026 was -23.6 M, a 209.52% decrease year-over-year.
- Recursion Pharmaceuticals, Inc. annual gross profit for 2025 was 3.7 M, a 72.59% decrease from 2024.
- Recursion Pharmaceuticals, Inc. annual gross profit for 2024 was 13.6 M, a 584.15% increase from 2023.
- Recursion Pharmaceuticals, Inc. annual gross profit for 2023 was 2.0 M, a 123.58% decrease from 2022.
- Recursion Pharmaceuticals, Inc. annual gross profit for 2022 was -8.4 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Recursion Pharmaceuticals, Inc. Gross Profit — FAQ
Recursion Pharmaceuticals, Inc. (RXRX) gross profit over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is Recursion Pharmaceuticals, Inc.'s gross profit?
Recursion Pharmaceuticals, Inc. (RXRX) reported gross profit of $4M for fiscal 2025.
Where can I see RXRX's gross profit history?
The chart and table above show Recursion Pharmaceuticals, Inc.'s gross profit by year and by quarter, including the growth rate.